The Stalwart Blog

OCTOBER 17, 2020

I have been following the vaccine trial development that a lot of pharmaceutical companies are undertaking right now. In other words, consumers will think that the pharmaceutical companies are being ineffective in their development. There’s a lot of things to watch on the news of late. That’s not necessarily the case.

Pharmaceuticals 78

Pharmaceuticals Publicity Government Reputation 78

Katie Paine's Measurement Blog

MARCH 29, 2023

Sometimes it’s a culture that bears the unmistakable mark of the CEO’s personality (like Turing Pharmaceuticals and Uber). Other times it’s the ineptitude of a CEO in communicating a key message in the face of a crisis (the poster child is BP’s Tony Hayward). Recently I went back and reviewed my old “Image Patrol” columns.

Crisis 52

Crisis Pharmaceuticals Social Media Comparison 52

PR Conversations

OCTOBER 27, 2023

I thought the new media offered tremendous potential for environmental scanning, issues management, rumor control, and crisis communication. I continue to believe the cyber media have great potential for research and listening, but I also see great potential for dialog, or two-way symmetrical communication.

Reputation 52

Reputation Social Media Internal International 52